MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
28815576
DOI
10.1111/epi.13870
Knihovny.cz E-zdroje
- Klíčová slova
- NGS, Hippocampal sclerosis, Mesial temporal lobe epilepsy, MicroRNA profiling, Target prediction, miQPCR,
- MeSH
- dospělí MeSH
- down regulace MeSH
- epilepsie temporálního laloku genetika metabolismus patologie chirurgie MeSH
- hipokampus metabolismus patologie chirurgie MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikro RNA genetika MeSH
- mladiství MeSH
- mladý dospělý MeSH
- počítačová simulace MeSH
- regulace genové exprese * MeSH
- sekvenční analýza RNA MeSH
- skleróza MeSH
- stanovení celkové genové exprese MeSH
- upregulace MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- mikro RNA MeSH
OBJECTIVE: Mesial temporal lobe epilepsy (mTLE) is a severe neurological disorder characterized by recurrent seizures. mTLE is frequently accompanied by neurodegeneration in the hippocampus resulting in hippocampal sclerosis (HS), the most common morphological correlate of drug resistance in mTLE patients. Incomplete knowledge of pathological changes in mTLE+HS complicates its therapy. The pathological mechanism underlying mTLE+HS may involve abnormal gene expression regulation, including posttranscriptional networks involving microRNAs (miRNAs). miRNA expression deregulation has been reported in various disorders, including epilepsy. However, the miRNA profile of mTLE+HS is not completely known and needs to be addressed. METHODS: Here, we have focused on hippocampal miRNA profiling in 33 mTLE+HS patients and nine postmortem controls to reveal abnormally expressed miRNAs. In this study, we significantly reduced technology-related bias (the most common source of false positivity in miRNA profiling data) by combining two different miRNA profiling methods, namely next generation sequencing and miRNA-specific quantitative real-time polymerase chain reaction. RESULTS: These methods combined have identified and validated 20 miRNAs with altered expression in the human epileptic hippocampus; 19 miRNAs were up-regulated and one down-regulated in mTLE+HS patients. Nine of these miRNAs have not been previously associated with epilepsy, and 19 aberrantly expressed miRNAs potentially regulate the targets and pathways linked with epilepsy (such as potassium channels, γ-aminobutyric acid, neurotrophin signaling, and axon guidance). SIGNIFICANCE: This study extends current knowledge of miRNA-mediated gene expression regulation in mTLE+HS by identifying miRNAs with altered expression in mTLE+HS, including nine novel abnormally expressed miRNAs and their putative targets. These observations further encourage the potential of microRNA-based biomarkers or therapies.
1st Department of Pathological Anatomy St Anne's University Hospital Brno Czech Republic
Central European Institute of Technology Masaryk University Brno Czech Republic
Department of Forensic Medicine St Anne's University Hospital Brno Czech Republic
Department of Neurology Brno Epilepsy Center St Anne's University Hospital Brno Czech Republic
Department of Neurosurgery St Anne's University Hospital Brno Czech Republic
Citace poskytuje Crossref.org
Dynamic miRNA changes during the process of epileptogenesis in an infantile and adult-onset model
Epilepsy miRNA Profile Depends on the Age of Onset in Humans and Rats
GENBANK
GSE99455